Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Conditions
Breast Cancer · Breast Cancer Metastatic · Hormone Receptor Positive Tumor · Human Epidermal Growth Factor 2 Negative Carcinoma of Breast · Ovarian Cancer · CCNE1 Amplification · Solid Tumor · Advanced Cancer · Metastatic Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Florida Cancer Specialists, Orlando, Florida, United States
Contact: Principal Investigator (Cesar Perez, MD)Emory Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Kevin M Kalinsky, MD)Georgia Cancer Center at Augusta University, Augusta, Georgia, United States
Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
Contact: Principal Investigator (Sunil Babu, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Antonio Giordano, MD)Karmanos Cancer Institute, Detroit, Michigan, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Principal Investigator (Sheheryar Kabraji, MD)Levine Cancer Institute (LCI)- Atrium Health, Charlotte, North Carolina, United States
Contact: Principal Investigator (Antoinette Tan, MD)Duke Cancer Center/ DUMC, Durham, North Carolina, United States
Contact: Principal Investigator (Carey Anders, MD)Gabrail Cancer Research Center, Canton, Ohio, United States
Contact: Principal Investigator (Nashat Gabrail, MD)Next Oncology, Dallas, Texas, United States
Contact: Principal Investigator (Michael Song, MD)UTSW Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (David Miller, MD)Oncology Consultants, Houston, Texas, United States
Contact: Principal Investigator (Julio Peguero, MD)Next Oncology, Houston, Texas, United States
Contact: Principal Investigator (Jennifer Segar, MD)Northwest Medical Specialties, PLLC, Tacoma, Washington, United States
Contact: Principal Investigator (Jorge Chaves, MD)Peninsula and South Eastern Haematology & Oncology Group, Frankston, Victoria, Australia
Contact: Principal Investigator (Vinod Ganju, MD)Peter MacCallum Cancer Center, Parkville, Victoria, Australia
Contact: Principal Investigator (George Au-Yeung, MD)Mater Hospital, South Brisbane, Australia
Contact: Principal Investigator (Catherine Shannon, MD)